"Clinilabs is a global, full-service CRO dedicated to providing a full range of CNS drug development services to pharmaceutical and biotechnology companies, from first-in-human to Phase 3 trials."

During the past decade, Clinilabs Drug Development Corporation conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 3 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinilabs Drug Development Corporation" #1 sponsor was "Larimar Therapeutics, Inc." with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Berg, LLC" with 2 trials sponsored, "Design Therapeutics" with 2 trials sponsored and "Inozyme Pharma" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinilabs Drug Development Corporation" #1 collaborator was "Metrum Research Group, LLC" with 2 trials as a collaborator, "Veristat, Inc." with 2 trials as a collaborator, "Clinilabs Drug Development Corporation" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator and "Drug Safety Navigator" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Clinilabs Drug Development Corporation" are "Friedreich Ataxia" (6 trials), "Healthy" (4 trials), "Major Depressive Disorder" (3 trials), "Generalized Arterial Calcification of Infancy" (2 trials) and "ATP-Binding Cassette Subfamily C Member 6 Deficiency" (1 trials). Many other conditions were trialed in "Clinilabs Drug Development Corporation" in a lesser frequency.

Most popular intervention types in "Clinilabs Drug Development Corporation" are "Drug" (15 trials), "Biological" (4 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "CTI-1601" (3 trials), "BPM31510 Oral Nanosuspension 4%" (2 trials), "DT-216" (2 trials) and "INZ-701" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinilabs Drug Development Corporation" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Clinilabs Drug Development Corporation". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Clinilabs Drug Development Corporation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinilabs Drug Development Corporation, 15 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".